Juluca (dolutegravir/rilpivirine)

Many patients pay $0 through manufacturer patient assistance programs. Contact our pharmacists — we handle all the paperwork.

Juluca is a complete two-drug regimen for virologically stable adults with HIV-1. It combines dolutegravir (an integrase strand transfer inhibitor) and rilpivirine (a non-nucleoside reverse transcriptase inhibitor) in a single tablet taken once daily with a meal.

Juluca is the first complete two-drug regimen approved for HIV maintenance therapy, minimizing long-term drug exposure.

• First complete two-drug HIV regimen
• Reduces long-term antiretroviral exposure
• Once daily with a meal
• 24/7 pharmacist access included